Heart rate
Conditions
Interventions
Experimental observation group: Esmolol hydrochloride injection (Recommended usage and dosage: Recommended dosage: Give or do not give the load, intravenous load dose of 500 µg/kg, about 1 min (if the
Sponsors
Shandong Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria (Those who meet all of the following criteria can be included in this clinical study) 1. Patients with various types of tachyarrhythmia clinically diagnosed; 2. Patients using Esmolol for fast heart rate control; 3. Age 18 or older, male or female; 4. Those who have signed the informed consent.
Exclusion criteria
Exclusion criteria: Exclusion criteria (persons with one of the following conditions are not eligible for inclusion in this clinical study) 1. Patients with contraindications contained in the instructions, including severe atrioventricular block, bradycardia, etc.; 2. Allergic to esmolol and its ingredients; 3. Patients with acute attack of bronchial asthma or history of severe chronic obstructive pulmonary disease or bronchial asthma; 4. Have participated in other related clinical studies or consider it inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The transition time required for rapid heart rate conversion to sinus rhythm or ventricular rate control; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure;Heart rate;Changes of PR interval and QTc interval before and after treatment;The recurrence rate of arrhythmia; | — |
Countries
China
Contacts
Public ContactZhou Yi
Shandong Provincial Hospital
Outcome results
None listed